These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35727945)

  • 21. Oligoclonal free kappa and lambda bands in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. An immunoaffinity-mediated capillary blot study.
    Sindic CJ; Laterre EC
    J Neuroimmunol; 1991 Jul; 33(1):63-72. PubMed ID: 1829093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis.
    Simonsen CS; Flemmen HØ; Lauritzen T; Berg-Hansen P; Moen SM; Celius EG
    Mult Scler J Exp Transl Clin; 2020; 6(1):2055217319901291. PubMed ID: 32030196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.
    Christiansen M; Gjelstrup MC; Stilund M; Christensen T; Petersen T; Jon Møller H
    Clin Chem Lab Med; 2018 Dec; 57(2):210-220. PubMed ID: 30055097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
    Front Immunol; 2019; 10():641. PubMed ID: 30984199
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of light chain type bands in CSF and serum oligoclonal IgG from patients with multiple sclerosis.
    Mehta PD; Mehta SP; Patrick BA
    J Neuroimmunol; 1982 Apr; 2(2):119-29. PubMed ID: 6802873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.
    Puthenparampil M; Altinier S; Stropparo E; Zywicki S; Poggiali D; Cazzola C; Toffanin E; Ruggero S; Grassivaro F; Zaninotto M; Plebani M; Gallo P
    Mult Scler Relat Disord; 2018 Oct; 25():241-245. PubMed ID: 30130707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Bayart JL; Muls N; van Pesch V
    Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigation.
    Rosenstein I; Rasch S; Axelsson M; Novakova L; Blennow K; Zetterberg H; Lycke J
    J Neurochem; 2021 Nov; 159(3):618-628. PubMed ID: 34478561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of sensitivities and specificities of cerebrospinal fluid free light chains to diagnose multiple sclerosis- a multicentric case-control study.
    Thevarkalam M; Krishnan S; Shanmughan LI; Mathai A; Leelamani JV; Kannoth S; Bhaskaran R; Iype T; Panda S
    Mult Scler Relat Disord; 2023 Jun; 74():104717. PubMed ID: 37062197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.
    Levraut M; Laurent-Chabalier S; Ayrignac X; Bigaut K; Rival M; Squalli S; Zéphir H; Alberto T; Pekar JD; Ciron J; Biotti D; Puissant-Lubrano B; Camdessanché JP; Tholance Y; Casez O; Toussaint B; Marion J; Moreau T; Lakomy D; Thomasset A; Maillart E; Sterlin D; Maurousset A; Rocher A; Laplaud DA; Bigot-Corbel E; Bertho PO; Pelletier J; Boucraut J; Labauge P; Vincent T; De Sèze J; Jahn I; Seitz-Polski B; Thouvenot E; Lebrun-Frenay C;
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36376096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal B cell-related markers for an optimized biological investigation of multiple sclerosis patients.
    Feki S; Damak M; Sakka S; Ben Ali Y; Mejdoub S; Bouattour N; Hachicha H; Mhiri C; Masmoudi H
    Sci Rep; 2022 Sep; 12(1):16425. PubMed ID: 36180495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the McDonald Criteria 2017 on Early Diagnosis of Relapsing-Remitting Multiple Sclerosis.
    Schwenkenbecher P; Wurster U; Konen FF; Gingele S; Sühs KW; Wattjes MP; Stangel M; Skripuletz T
    Front Neurol; 2019; 10():188. PubMed ID: 30930829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reiber's Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?
    Schwenkenbecher P; Konen FF; Wurster U; Witte T; Gingele S; Sühs KW; Stangel M; Skripuletz T
    Diagnostics (Basel); 2019 Nov; 9(4):. PubMed ID: 31744096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of CSF kappa free light chains for the diagnosis of multiple sclerosis (MS): a comparison with oligoclonal bands (OCB) detection via isoelectric focusing (IEF) coupled with immunoblotting.
    Abid MA; Ahmed S; Muneer S; Khan S; de Oliveira MHS; Kausar R; Siddiqui I
    J Clin Pathol; 2023 May; 76(5):353-356. PubMed ID: 36130824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.
    Kolčava J; Kočica J; Hulová M; Dušek L; Horáková M; Keřkovský M; Stulík J; Dostál M; Kuhn M; Vlčková E; Bednařík J; Benešová Y
    Mult Scler Relat Disord; 2020 Sep; 44():102262. PubMed ID: 32570179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
    Pfuhl C; Grittner U; Gieß RM; Scheel M; Behrens JR; Rasche L; Pache FC; Wenzel R; Brandt AU; Bellmann-Strobl J; Paul F; Ruprecht K; Oechtering J
    Neurology; 2019 Oct; 93(15):e1439-e1451. PubMed ID: 31501228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis.
    Krakauer M; Schaldemose Nielsen H; Jensen J; Sellebjerg F
    Acta Neurol Scand; 1998 Sep; 98(3):161-5. PubMed ID: 9786611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kappa-index: Real-life evaluation of a new tool for multiple sclerosis diagnosis.
    Marlas M; Bost C; Dorcet G; Delourme A; Biotti D; Ciron J; Renaudineau Y; Puissant-Lubrano B
    Clin Immunol; 2022 Aug; 241():109066. PubMed ID: 35705146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.
    Gaetani L; Di Carlo M; Brachelente G; Valletta F; Eusebi P; Mancini A; Gentili L; Borrelli A; Calabresi P; Sarchielli P; Ferri C; Villa A; Di Filippo M
    J Neuroimmunol; 2020 Feb; 339():577108. PubMed ID: 31743879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.
    Hegen H; Walde J; Milosavljevic D; Aboulenein-Djamshidian F; Senel M; Tumani H; Deisenhammer F; Presslauer S
    Clin Chem Lab Med; 2019 Sep; 57(10):1574-1586. PubMed ID: 31112501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.